ORAGIN’s Future of Cheese Receives U.S. Food and Drug Administration (FDA) Registration, Allowing for North American Wide Direct Sales

Oragin Foods Inc. (“ORAGIN” or the “Company”) (TSXV: OG) (OTCQX: OGGFF) (FRA: 9CW) is pleased to announce that its wholly-owned subsidiary, Future of Cheese Inc. (“FoC”), has been notified of its successful registration with the U.S. Food and Drug Administration (the “FDA”). This significant milestone allows FoC to commence its production and sales plans within the U.S. market.

“This is a significant step towards our plans to enter the U.S. market and supply the growing demand for Future of Cheese products from consumers and retailers in the United States,” said Jen Wojtaszek, President of Future of Cheese.

The FDA requires domestic and foreign companies that manufacture, process, pack, or hold food for human or animal consumption in the United States to register with the FDA in order to sell products to consumers. Upon approval, the FDA assigns a registration number to confirm that a food facility is registered. This was the final step required to allow Future of Cheese to commence sales and ship its products into the U.S. market, which the company plans to do initially through its upcoming e-commerce platform.

“Inquiries and demand for our products through our digital and social media outlets have soared since launching our highly successful plant-based Brie, which received a tremendous reception from media outlets in the U.S., reinforcing the opportunity for us to drive sales directly through our online channels,” said Ms. Wojtaszek. “This FDA registration sets us up to be able to fulfil that demand with the upcoming launch of our North American-wide e-commerce platform.”

The Company also announces the grant of 100,000 options pursuant to its stock option plan to Mr. Michael Lovsin, a director of the Company. The options are exercisable at $0.32 for a period of 5 years (subject to earlier termination), vesting as to 25% each on the 3, 6, 9 and 12 month anniversaries of the date of grant.

Mr. Lovsin will step into a more active operational role within the Company, overseeing the development of the CPG division, which includes the Future of Cheese. Mr. Lovsin is an accomplished executive with more than 35 years of experience in retail, including natural foods, pharmacy, product development, regulatory affairs, food safety and quality management systems for both corporate and national brands. Mr. Lovsin recently headed the reinvention of the brand strategy for Coles Supermarkets, Australia’s second largest supermarket, and previously held executive roles at Canada’s largest grocery retailer Loblaws, as Senior Vice President of Health & Wellness and Senior Vice President of Loblaw Brands, ULTA Beauty as Vice President of Merchandising, and Vice President of Category Management at Shoppers Drug Mart, Canada’s largest drug store chain.